Safety, Pharmacokinetics, and Pharmacodynamics of MK-2248 in Participants With Hepatitis C (MK-2248-002)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)
- Status
- COMPLETED
- Phase
- PHASE4
A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400)
- Status
- COMPLETED
- Phase
- PHASE2
The Differential Effects of Diabetes Therapy on Inflammation
- Status
- COMPLETED
- Phase
- N/A
Social Forces to Improve Statin Adherence (Study B)
- Status
- COMPLETED
- Phase
- NA
Comparison of Low Versus Normal Pressure Pneumoperitoneum - With Profound Low Versus Normal Pressure Pneumoperitoneum -With Profound Muscle Relaxation- During Laparoscopic Donor Nephrectomy
- Status
- COMPLETED
- Phase
- NA
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
- Status
- COMPLETED
- Phase
- PHASE3
Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
- Status
- COMPLETED
- Phase
- PHASE3
A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)
- Status
- COMPLETED
- Phase
- PHASE2
Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
- Status
- COMPLETED
- Phase
- PHASE3
Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetics, Safety, and Tolerability of Ertugliflozin (MK-8835/PF-04971729) in Participants With Hepatic Impairment and in Healthy Participants (MK-8835-014)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Study to Compare Immune Response of V503 to Gardasil in 16- to 26-year-old Men (V503-020)
- Status
- COMPLETED
- Phase
- PHASE3
Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects
- Status
- TERMINATED
- Phase
- PHASE1